KWILP
RCUS icon

Kiwi Wealth Investments Limited Partnership’s Arcus Biosciences RCUS Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-55,409
Closed -$1.13M – 166
2023
Q2 		$1.13M Hold
55,409
– – 0.07% 160
2023
Q1 		$1.01M Hold
55,409
– – 0.07% 148
2022
Q4 		$1.15M Buy
+55,409
New +$1.52M 0.08% 160

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's RCUS Position: Q3 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 55,409 shares — an estimated $1.13M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in RCUS in Q4 2022 and held it in 3 quarters. The position peaked at $1.15M in Q4 2022. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 55,409 Arcus Biosciences shares in Q3 2023, an estimated $1.13M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Arcus Biosciences in Q4 2022 and held it in 3 quarters.
  • Kiwi Wealth Investments Limited Partnership's Arcus Biosciences position peaked at $1.15M in Q4 2022.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.